ADVERTISEMENT



Google       

Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz

OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense

Find a Local Lawyer

Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402

Bookmark

Patent Law

: IPBiz

Sanofi's PARP inhibitor

By Lawrence B. Ebert, Esq.

ADVERTISEMENTS
Sanofi-Aventis bought BiPar to obtain rights to BiPar's BSI-201, which belongs to a new class of drugs that block a cell repair enzyme known as PARP. An issue is that BiPar's main composition patent in the US runs out in 2013, although it might be extended.

Full post as published by IPBiz on June 02, 2009 (boomark / email).

Bloggers, promote your law blog by nominating your blog for inclusion in USLaw.com's Law Blog Directory and RSS Reader. Benefits described.
Related Law Articles

Bextra Product Recall
Find a Bextra Lawyer

Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack

Related Searches

























































































































US Law
#1 Online Legal Resource













Your Blog Subscriptions
Subscribe to blogs

10,000+ Law Job Listings
Lawyer . Police . Paralegal . Etc
Earn a law-related degree
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.


Practice Area
Zip Code:

Contact a Lawyer Now!






0.0123 secs (new cache)